Diabetic KK-A(y) mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen

Kazuyoshi Kon1, Kenichi Ikejima, Kyoko Okumura

  • 1Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Insights

Metabolic syndrome exacerbates acetaminophen liver injury. Diabetic mice showed increased cell death and oxidative stress, indicating higher susceptibility to acetaminophen toxicity.

Area of Science:

  • Hepatology
  • Toxicology
  • Metabolic Syndrome Research

Background:

  • Nonalcoholic steatohepatitis (NASH) shares similarities with alcoholic liver disease.
  • Susceptibility to acetaminophen hepatotoxicity in NASH is not well understood.

Purpose of the Study:

  • Investigate acetaminophen-induced liver injury in a metabolic syndrome mouse model (KK-A(y) mice).
  • Determine if metabolic syndrome exacerbates acetaminophen toxicity.

Main Methods:

  • Administered acetaminophen to KK-A(y) and C57Bl/6 mice.
  • Assessed liver histology, oxidative stress markers (4-hydroxy-2-nonenal, reduced glutathione), and JNK phosphorylation.
  • Evaluated hepatocyte cell death and oxidative stress in vitro.

Main Results:

  • KK-A(y) mice exhibited more severe necrosis and apoptosis after acetaminophen exposure.
  • Elevated serum alanine aminotransferase levels were observed in KK-A(y) mice.
  • Increased oxidative stress and JNK phosphorylation were noted in KK-A(y) mouse livers and hepatocytes.

Conclusions:

  • Acetaminophen toxicity is increased in diabetic KK-A(y) mice due to enhanced hepatocyte oxidative stress.
  • Metabolic syndrome-related steatohepatitis appears to be an exacerbating factor for acetaminophen-induced liver injury.

Related Concept Videos